Efficient Extraction of Virus DNA by NucliSens Extractor Allows Sensitive Detection of Hepatitis B Virus by PCR
Open Access
- 1 December 2001
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (12) , 4339-4343
- https://doi.org/10.1128/jcm.39.12.4339-4343.2001
Abstract
The NucliSens Extractor is an automated nucleic acid isolation system based on guanidinium thiocyanate (GuSCN)-silica extraction technology. The system has been validated for the isolation of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) RNAs from human samples in combination with nucleic acid sequence-based amplification- and reverse transcription-PCR-based methods. We evaluated the extractor for hepatitis B virus (HBV) DNA extraction from human samples using a noncommercial HBV DNA PCR. Several sample pretreatment procedures in combination with the extractor were compared with the Qiagen extraction method, and the impact of the sample volume used in the extraction on the sensitivity was investigated. Heating of the lysed sample prior to extractor isolation and the use of a large sample volume resulted in highly sensitive detection of HBV DNA. Incubation of a 1-ml sample in GuSCN at 80°C (10 min) and at 37°C (30 min) allowed detection of 4 and 40 HBV genome equivalents/ml, respectively, in standard dilution panels. Sample lysis in GuSCN at room temperature and proteinase K treatment prior to use of the extractor were less efficient procedures. All clinical samples that were PCR positive after Qiagen extraction and/or that were HBsAg positive were also PCR positive after extractor isolation. HBV DNA, HCV RNA, and HIV type 1 RNA were efficiently coextracted from a single sample, allowing reliable detection of viral genomes.Keywords
This publication has 15 references indexed in Scilit:
- Validation of the NucliSens Extractor in combination with the hepatitis C virus Cobas Amplicor 2.0 assay in four laboratories in the Netherlands utilizing nucleic acid amplification technology for blood screeningVox Sanguinis, 2001
- Screening Blood Donations for Hepatitis C Virus by Polymerase Chain ReactionVox Sanguinis, 2000
- Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank settingThe Lancet, 1999
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infectionJournal of Hepatology, 1996
- A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probesJournal of Virological Methods, 1994
- Quantification of HIV-1 RNA in plasma using NASBAtm during HIV-1 primary infectionJournal of Virological Methods, 1993
- Mutations in the Precore Region of Hepatitis B Virus DNA in Patients with Fulminant and Severe HepatitisNew England Journal of Medicine, 1991
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982
- Hepatitis B virus contains protein attached to the 5′ terminus of its complete DNA strandCell, 1980